ArticleScientific reports2026
Simple and efficient co-synthesis of gold nanoparticles and nanoclusters for HPV-16 detection.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The detection of HPV-16 is essential for cervical cancer molecular diagnostics at the point of care and in the early stages. Current diagnostic methods, however, find it difficult to balance cost-effectiveness with good analytical performance. We have created a unique nanobiosensor that uses colorimetric and fluorometric techniques to identify the HPV-16 L1 gene sequence in order to overcome this difficulty. By using particular probe-polyadenine (A₂₀) strands, we rapidly synthesized a mixed population of anisotropic gold nanoparticles (AuNPs) and ultrasmall gold nanoclusters (AuNCs) in situ, both produced through the same DNA-templated reduction process. Gel electrophoresis, UV-Vis spectroscopy, transmission electron microscope (TEM), fluorescence spectroscopy, dynamic light scattering (DLS), and visual inspection were used to characterize the nanobiosensor. These analyses confirmed that the Poly(A)₂₀ strand facilitates the formation of anisotropic AuNPs and AuNCs, resulting in a dense layer of functionalized DNA on each nanoparticle and the formation of polyvalent (p)DNA-AuNP-AuNC, while also confirming the detection of the HPV-16 L1 gene sequence. The sensor successfully detected pUCm-T containing the HPV-16 L1 insert across a concentration range of 0.78 nM to 15.6 nM, with a limit of detection (LOD) of 3.5 nM via direct AuNP signaling and 3.11 nM through indirect peroxidase-like activity. The colorimetric assay showed clear and distinguishable color changes upon target DNA binding, highlighting the peroxidase-like activity of the AuNPs as a reliable detection signal. Meanwhile, the fluorometric assay provided a strong fluorescent signal with high contrast between test and control samples, confirming its effectiveness in differentiating positive samples from negative ones. Overall, the nanobiosensor demonstrated robust sensitivity, excellent repeatability, high specificity toward HPV-16, and a reliable operational lifespan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.